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The present invention provides a new process for the prepa-
ration of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-
phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride,
wherein this compound is prepared directly from the chlo-
romethylalcohol. Importantly, the process of the present
invention results in higher yields of 2S,3S-N-isobutyl-N-(2-
hydroxy -3 -amino -4-phenylbu tyl) -p-
nitrobenzenesulfonylamide hydrochloride without sacrific-
ing its purity. The processes of the present inventin can be
used to prepare not only the 2S,3S-derivative, but also the
2R,3S-, 2S,2R- and the 2R,3R-derivatives.
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PREPARATION OF 2S,3S-N-ISOBUTYL-N-(2-
HYDROXY-3-AMINO-4-PHENYLBUTYL) -P-
NITROBENZENESULFONYLAMIDE
HYDROCHLORIDE AND OTHER
DERIVATIVES OF 2-HYDROXY-l,3-
DIAMINES
This application claims the benefit of provisional appli-
cation serial No. 60/172,043, filed Dec. 23, 1999.
CROSS-REFERENCE TO RELATED
APPLICATION
This patent application claims the benefit of U.S. Provi-
sional Patent Application No. 60/172,043, filed Dec. 23,
1999, which is incorporated herein by reference in its
entirety for all purposes.
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85° C. to about 90° C. gives Compound III, i.e., 2S,3S-N-
isobuty1- N -(2-hydroxy-3 -amino -4-phenylbu ty1) -p-
nitrobenzenesulfonylamide hydrochloride, in 64% overall
yield.
5 Unfortunately, this process has a number of drawbacks.
Some of the drawbacks associated with this process include
high reaction temperatures which lead to the formation of
side products; low solubility of intermediates in the reaction
solvent which requires high processing temperatures during
10 work-up which, in turn, leads to longer cycle times, material
handling losses, etc.; and the like. As such, there remains a
need in the art for an improved process for preparing 2S,3
S-N-isobuty1-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-
nitrobenzenesulfonylamide hydrochloride which overcomes
15 the drawbacks associated with the currently used process.
Quite surprisingly, the present invention fulfills this and
other needs.
BACKGROUND OF THE INVENTION
SUMMARY OF THE INVENTION
DESCRIPTION OF THE INVENTION AND
PREFERRED EMBODIMENTS
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates the process previously used to prepare
2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-
nitrobenzenesulfonylamide hydrochloride.
It has now been discovered that a protease inhibitor
intermediate, i.e., 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-
4 -p he n yl bu t yl) -p - ni tro b e nze ne s ulfo n yl amide
hydrochloride, can be prepared directly from a halomethy-
lalcohol (HMA) (e.g., chloromethylalcohol) without having
to isolate the Boc-epoxide. As such, the present invention
provides a new process for the preparation of 2S,3S-N-
isobuty1- N -(2-hydroxy-3 -amino -4-phenylbu ty1) -p-
nitrobenzenesulfonylamide hydrochloride, i.e., Compound
III, wherein this compound is prepared directly from a
HMA. Importantly, the process of the present invention
results in higher yields of Compound III, while not sacri-
The present invention provides a new process for the
preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-
phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride,
i.e., Compound III. In this new process, one of the chemical
steps (i.e., the epoxide step) as well as material handling
losses associated with the previously used process have been
eliminated. More particularly, using the process of the
present invention, the halomethylalcohol, i.e., HMA, (e.g.,
chloromethylalcohol) is successfully converted to Com-
pound III directly without the need to isolate the Boc-
epoxide. Numerous publications have described the synthe-
sis of Compound I-like materials, but they all involve
reaction of an epoxide with an amine. As such, the process
of the present invention is the first example of a process
wherein a protease inhibitor intermediate is prepared
35 directly from the halomethyialcohoi. Moreover, the process
of the present invention results in a higher yield of Com-
pound III, while not sacrificing its purity. In addition, the
process of the present invention allows for the use of the
lower purity HMA, thereby eliminating a purification step.
Finally, it is pointed out that elimination of the epoxide step
eliminates the need to isolate a toxic intermediate (i.e., a
mutagen) and, thus, circumvents safety issues involved with
dust explosivity of the Boc-epoxide.
Other features, objects and advantages of the invention
and its preferred embodiments will become apparent from
the detailed description which follows.
50
Human immunodeficiency virus (HIV), the causative 20
agent of acquired immunodeficiency syndrome (AIDS),
encodes three enzymes, including the well-characterized
proteinase belonging to the aspartic proteinase family, the
HIV protease. Inhibition of this enzyme has been regarded
as a promising approach for treating AIDS. Hydroxyethy- 25
lamine isosteres have been extensively utilized in the syn-
thesis of potent and selective HIV protease inhibitors.
However, this modem generation of HIV protease inhibitors
has created an interesting challenge for the synthetic organic
chemist. Advanced x-ray structural analysis has allowed for 30
the design of molecules that fit closely into active sites on
enzymes creating very effective drug molecules.
Unfortunately, these molecules, designed by molecular
shape, are often difficult to produce using conventional
chemistry.
The modern generation of HIV inhibitors has structural
similarities in a central three-carbon piece containing two
chiral carbons that link two larger groups on each side (see,
e.g., Parkes, et aI., J. Org. Chern., 59:3656 (1994)). In
general, the chemical bond from the central part to one of the 40
larger groups is a carbon-nitrogen bond which is usually
accomplished by reacting an epoxide with an amine. 2S,3S-
N-isobuty1-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-
nitrobenzenesulfonylamide hydrochloride is a key interme-
diate in the synthesis of protease inhibitors (see, e.g., U.S. 45
Pat. Nos. 5,585,397, 5,723,490 and 5,783,701 as well as
PCT International Publication No. WO 94/05639, the teach-
ings of all of which are incorporated herein by reference).
The process currently used to prepare 2S,3S-N-isobutyl-N-
(2 - hydro xy - 3 - am ino - 4 -p he n yl bu t yl) -p-
nitrobenzenesulfonylamide hydrochloride is illustrated in
Figure I.
As illustrated in Figure I, 2S,3S-N-isobutyl-N-(2-
hydroxy-3 - amino -4-phenylbu tyl) -p-
nitrobenzenesulfonylamide hydrochloride is prepared by a 55
4-step process starting from a commercially available
(Aerojet Fine Chemicals (Sacramento, Calif.)) starting
material, 2S,3S-chloromethylalcohol (2S,3S-CMA). In the
first step, 2S,3S-CMA is reacted with sodium hydroxide in
THF/ethanol to give the corresponding epoxide in 91% 60
yield. In the second step, the epoxide is dissolved in toluene
and reacted with excess isobutylamine at a temperature of
about 75° C. to about 80° C. to give Compound I. Reaction
of Compound I with p-nitrobenzenesulfonyl chloride (i.e.,
nosyl chloride) in toluene at a temperature of about 85° C. 65
to about 90° c., followed by deprotecting of the Boc
protecting group with aqueous HCl at a temperature of about
US 6,548,706 B2
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ficing its purity. Moreover, the process of the present inven-
tion can be used to prepare not only the 2S,3S-derivative, but
also the 2R,3S-, 2S,2R- and the 2R,3R-derivatives.
t-BocHN
10
In the above process, a HMA is reacted with an amine at
15 a temperature ranging from about 50° C. to 100° C. to give
the compound of Formula I in high yields. In a presently
preferred embodiment, the HMA is reacted with an amine at
a temperature ranging from about 60° C. to about 75° C. to
give the Compound of Formula I in very high yields (about
20 98-99% yield). The amine used in the above process can be
a primary amine, a secondary amine, a substituted amine
(e.g., N-substituted sulfonamides, etc.), hydrazines and sub-
stituted hydrazines (e.g., N-substituted hydrazine, etc.).
Exemplar amines include, but are not limited to,
methylamine, ethylamine, isopropylamine, n-butylamine,
25 isobutylamine, cyclohexylamine, benzylamine, para-
nitrobenzylamine, dimethylamine, isobutylmethylamine,
decahyroquinoline, decahydroisoquinoline, pyrimidine,
iso bu t yIp ar ani tro be nze ne s ulfo n amide,
me th yIp ar ani tro b e nze ne s ulfo n am ide,
30 isobutylmetanitrobenzenesulfonamide, hydrazine, substi-
tuted hydrazines, etc.
In a presently preferred embodiment, the amine employed
in the above process is isobutylamine (lEA). Importantly,
the solvent employed in the previously used method (i.e.,
35 toluene) has been eliminated and, in this embodiment, the
reaction is conducted in neat IBA, using IBA as the reaction
solvent. This simplifies the lEA recovery process (no frac-
tional distillation/column needed to separate lEA from
toluene), and allows for the reaction to be carried out at
40 slightly lower temperatures. It has been found, however, that
under theses conditions, the reaction times can be relatively
long (-30 h). To reduce reaction times, it has been discov-
ered that an acid scavenger can be added to the reaction
mixture.
As such, in one embodiment of the above process, an acid
scavenger is added to the reaction mixture to reduce reaction
times. In a preferred embodiment, the acid scavenger has the
general formula: M+B-, wherein M+ is selected from the
group consisting of K+, Na+, Li+, Ca+2 , Mg+2 and Al+2 ; and
50 B- is selected from the group consisting of -OH, HC03 - and
C03-2. In a preferred embodiment, the acid scavenger is
sodium bicarbonate. In another preferred embodiment, the
acid scavenger is potassium bicarbonate. When an acid
scavenger is added to the reaction mixture, about 0.5 to 2
55 equivalents are added. In a presently preferred embodiment,
about 1 equivalent of the acid scavenger is added to the
reaction mixture. It has been found that by adding even only
1.05 equivalents of an acid scavenger (e.g., sodium
bicarbonate) to the reaction mixture, the reaction times can
60 be reduced from 30 hours to less than 4 hours. Moreover,
this reduction in reaction times can be achieved without
sacrificing product quality and/or yield. It will be readily
apparent to those of skill in the art that other acid scavengers,
base phosphates, etc. can be used in the methods of the
65 present invention to reduce reaction times.
Thus, as illustrated in Table I, the reaction rates of the base
catalyzed reaction of chloromethylalcohol (CMA) with
Cl.
OH
t-BocHN
In another preferred embodiment, the Compound of For-
mula I has the following formula:
In the above process, X is a leaving group (e.g., a halo
group, such as chloro, bromo, fiuoro or iodo, a tosylate
group, a mesylate group, etc.); R1 is an amino acid side chain
or a functionalized amino acid side chain (e.g., an alkyl
group, a benzyl group, a phenyl thiomethyl group, a pro-
tected hydroxymethyl group, an S-alkyl group, a nitroben-
zenyl group, etc.); R2 is a protecting group (e.g., t-Boc
(tert-butyloxycarboxy), i-Boc (iso-butyloxycarboxy), Cbz
(benzyloxycarboxy), MOC (methoxycarboxy), Fmoc
(fiuorenylmethoxycarbonyl), dibenzyl, etc.); and R3 and R4
are independently selected and are functional groups
including, but not limited to, hydrogen, alkyl, cycloalkyl, 45
aryl and -NHP, wherein P is selected from the group
consisting of H, alkyl, cycloalkyl, aryl and a protecting
group or, alternatively, R3 and R4 together can form a cyclic
structure including, but not limited to, quinoline and
isoquinoline, etc.
In a preferred embodiment, the HMA is a 2S,3S-
halomethylalcohol (2S,3S-HMA). In a presently preferred
embodiment, the 2S,3S-HMA has the following formula:
the process compnsmg: combining a halomethylalcohol,
e.g., chloromethylalcohol, with an amine, e.g., isobuty-
lamine (lEA), to form a reaction mixture, and heating the
reaction mixture until the reaction is complete, thereby
forming the compound of Formula I, wherein the HMA has
the following general formula:
5As such, the first step in the process for preparing a
Compound of Formula III involves the preparation of a
compound having the following general formula:
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isobutylamine are comparable to those of the epoxide with
isobutylamine, with the reaction being substantially com-
plete in 3 hours.
Rxn Time (h)
TABLE I
% Compound I
5
In another preferred embodiment, the Compound of For-
mula II has the following general formula:
30
t-BocHN NH
OH Y
35
10 and, (c) adding the first reaction mixture with the second
reaction mixture to form a third reaction mixture, and
heating the third reaction mixture until the reaction is
complete, thereby forming the compound of Formula II.
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting
15 group; and R3 and R4 are independently selected and are
functional groups including, but not limited to, hydrogen,
alkyl, cycloalkyl, aryl and -NHP, wherein P is selected
from the group consisting of H, alkyl, cycloalkyl, aryl and
a protecting group or, alternatively, R3 and R4 together can
20 form a cyclic structure including, but not limited to, quino-
line and isoquinoline. In a presently preferred embodiment,
the compound of Formula I has the following general
formula:
0.15
90.8
97.7
98.6
98.8
o
1
2
3
4
TABLE II
Reaction # Scale* Yield Purity
CP086-135 (HP) 100 g 98.5% 98.8%
CP086-143 (HP) 100 g 98.5% 98.7%
CP086-147 (HP) 100 g NO 98.8%
CP086-160 (HP) 250 g 99% 98.8%
Moreover, it is pointed out that the Boc-epoxide
employed in the previously used method is thermally
unstable, and at higher temperatures (>70° C.) will undergo
a deprotecting reaction to give free amine which, in turn,
leads to a variety of side-reactions. In contrast, HMA, e.g.,
CMA, is more thermally stable than Boc-epoxide. The
higher thermal stability of HMA, e.g., CMA, coupled with
lower reaction/processing temperatures allows for Com-
pound III to be prepared in a much higher yield and purity.
Moreover, using the above process, the purity of isolated 25
Compound I is in the neighborhood of 98.7 to 98.8% (area
%) by HPLC. Typical results for the reaction of 2S,3S-CMA
with isobutylamine to give Compound I are illustrated
below:
In one embodiment, the above process further comprises 40
recovering (e.g., isolating and purifying) the Compound of
Formula I from the reaction mixture. However, in a pres-
ently preferred embodiment, the Compound of Formula I is
filtered and used in the next step without first being purified. 45
The second step in the process for preparing a Compound
of Formula III involves the preparation of a compound
having the following general formula:
50
t-BocH
II
the process compflsIng: (a) combining
p-nitrobenzenesulfonyl chloride, i.e., nosyl chloride, with an
alkyl acetate to form a first reaction mixture; (b) combining
a tertiary amine (e.g., triethylamine (TEA)) with a com-
pound of Formula I in an aromatic solvent (e.g., toluene) to
form a second reaction mixture, the compound of Formula
I having the following general formula:
In the first step of the above process, nosyl chloride is
combined with an alkyl acetate to form a first reaction
mixture. Alkyl acetates suitable for use include, but are not
55 limited to, methyl acetate, ethyl acetate, isopropyl acetate,
isobutyl acetate, etc. In a presently preferred embodiment,
ethyl acetate is employed. In the second step of the above
process, a tertiary amine is combined with a Compound of
Formula I in an aromatic solvent to form a second reaction
60 mixture. Exemplar tertiary amines include, but are not
limited to, triethylamine, diisopropylethylamine, pyridine
and N-methylmorpholine. In a presently preferred
embodiment, triethylamine is used. Suitable aromatic
solvents, include, but are not limited to, toluene, benzene
65 and xylene. In a presently preferred embodiment, toluene is
used. In the third step of the above process, the first reaction
mixture is added to the second reaction mixture to form a
US 6,548,706 B2
Cl.
OH
6
z
t-BocHN
In the above process, the HMA is reacted with a sulfona-
mide. Suitable sulfonamides include those having the fol-
lowing general formula:
wherein: R5 and R6 are independently selected and are
functional groups including, but not limited to, alkyl,
cycloalkyl and aryl. In a preferred embodiment, R5 is alkyl
and R6 is aryl. In a further preferred embodiment, the aryl
has the general formula:
8
In a preferred embodiment, the HMA is a 2S,3S-
halomethyl-alcohol (2S,3S-HMA). In a presently preferred
embodiment, the 2S,3S-HMA has the following formula:
45
wherein: Z is a functional group including, but not limited
to, hydrogen, alkyl, halogen, hydroxy, alkoxy, -N02 and
40 -NAP, wherein P is a protecting group. In a preferred
embodiment, the sulfonamide is selected from the group
consisting of isobutylparanitrobenzenesulfonamide, isobu-
tylmetanitrobenzenesulfonamide and isobutylorthonitroben-
zenesulfonamide.
In one embodiment of the above process, an acid scav-
enger can be added to the reaction mixture to reduce reaction
times. In a preferred embodiment, the acid scavenger has the
general formula: M+B-, wherein M+is selected from the
group consisting of K+, Na+, Li+, Ca+2 , Mg+2 and Al+2 ; and
50 B-is selected from the group consisting of -OH, HC03-and
C03-2. In a preferred embodiment, the acid scavenger is
sodium bicarbonate. In another preferred embodiment, the
acid scavenger is potassium bicarbonate. When an acid
scavenger is added to the reaction mixture, about 0.5 to 2
55 equivalents are added. In a presently preferred embodiment,
about 1 equivalent of the acid scavenger is added to the
reaction mixture. In this process, a HMA is reacted with a
sulfonamide at a temperature ranging from about 50° C. to
125° C. to give the compound of Formula II in high yields.
60 In a presently preferred embodiment, the HMA is reacted
with a sulfonamide at a temperature ranging from about 60°
C. to about 80° C. to give the Compound of Formula II in
very high yields.
The final step in the process of the present invention
65 involves the conversion of a Compound of Formula II to a
Compound of Formula III, the Compound of Formula III
having the following general formula:
II
7
the process compnsmg: combining a halomethyl alcohol
(HMA) with a sulfonamide to form a reaction mixture, and
heating said reaction mixture until the reaction is complete,
thereby forming the compound of Formula II, wherein said
HMA has the following general formula:
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting
group; R3 is a functional group including, but not limited to,
hydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein P is
selected from the group consisting of H, alkyl, cycloalkyl,
aryl and a protecting group; R4 is a functional group
including, but not limited to, alkyl, cycloalkyl and aryl; and
X is a leaving group.
third reaction mixture, and the third reaction mixture is
heated until the reaction is complete. In a presently preferred
embodiment, the first reaction mixture is heated or warmed
prior to adding it to the second reaction mixture. The third
reaction mixture is heated to a temperature ranging from 5
about 50° C. to about 100° C. and, more preferably, to a
temperature ranging from about 60° C. to about 75° C.
Ethyl acetate is a good solvent for Compound I and
Compound II intermediates; however, under certain condi-
tions, Compound I will react with ethyl acetate to give 10
N-acetyl Compound I. As such, it has now been surprisingly
discovered that the best way to carry out the above process,
i.e., the second step in the preparation of the Compound of
Formula III, is to dissolve the nosyl chloride in ethyl acetate 15
(nosyl chloride is not very soluble in toluene), and then add
it to a solution of the Compound of Formula I in toluene that
has been warmed to a temperature of about 70° C. Under
these conditions, the reaction is instantaneous and is com-
plete when the addition is done. Moreover, since nosyl 20
chloride is much more reactive than ethyl acetate, formation
of the N-acetyl Compound I is not detected. Further, addi-
tion of ethyl acetate to the reaction mixture improves the
solubility of Compound II in the reaction mixture, thereby
allowing the processing to be conducted at about 70° C. 25
instead of at about 85° C. Use of ethyl acetate as a co-solvent
also improves the partitioning of the Compound of Formula
II into the organic phase and, thus, minimizes loss due to
product loss in aqueous phase. Further, use of lower reaction
temperature (70° C. versus 85-90° C.) also improves the 30
quality of the Compound of Formula II since side reactions,
such as de-protecting, etc., are minimized at lower tempera-
tures.
In an alternative embodiment, the Compound of Formula
II can be prepared directly from a HMA. As such, the present 35
invention provides a process for the preparation of a com-
pound having the general formula:
US 6,548,706 B2
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In step (b) of the above process, the reaction mixture is
treated or contacted with an acid having a pKa of less than
about 4. Suitable acids include, but are not limited to, HCI,
HEr, CF3 C02 H, CF3S03 H, CH3S03 H, H2S04 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The
reaction mixture is treated with the acid for a time period of
at lease about 0.5 hours and, typically, for a period of time
ranging from about 1 to about 5 hours. In a presently
preferred embodiment, the acid is aqueous hydrochloric acid
(HCI). In this embodiment, the hydrochloric acid can be, for
example, about 37 % aqueous hydrochloric acid. In another
preferred embodiment, the hydrochloric acid is gaseous
hydrochloric acid. In this embodiment, the gaseous hydro-
chloric acid can be bubbled through the reaction mixture. In
another presently preferred embodiment, the acid is meth-
anesulfonic acid (CH3S03 H). In a presently preferred
embodiment, the Compound of Formula III is recovered
30 from the reaction mixture.
In addition to the foregoing, it has also been discovered
that a halogenated solvent (e.g., methylene chloride) is a
superior solvent than toluene or toluene/ethyl acetate for
synthesizing the Compounds of Formulae II and III. The
35 higher solubility of Compound I-III intermediates in a
halogenated solvent (e.g., methylene chloride) allows for the
reactions to be carried out at much lower temperatures
(about 30 to 35° C. lower than the toluene/ethyl acetate
process and about 45-50° C. lower than the toluene
40 process). The ability to conduct the reactions at lower
temperatures has a profound effect on the quality and yield
of the resulting material. Low reaction temperatures mini-
mize decomposition and other side-reactions (e.g.,
deprotecting), thereby leading to products with fewer impu-
45 rities which, in turn, leads to improved quality and higher
yield (15 to 20% higher yield). It has been found that the rate
of the deprotecting reaction with, for example, aqueous HCI
is much slower in a halogenated solvent (e.g., methylene
chloride) than in toluene or toluene/ethyl acetate. For
example, in toluene/ethyl acetate the time required to
achieve >99% conversion is about 3 hours, whereas in
methylene chloride, it is nearly 5 days. However, it has
surprisingly been discovered that the use of, for example,
gaseous HCI, instead of aqueous HCI, will reduce the
55 reaction time from 5 days to 3 hours. An additional advan-
tage for using gaseous HCI is that it does not require
additional stripping to remove the water. When HCI is
employed as the acid, the final product (Compound III) is a
hydrochloride salt, and it is important to remove water in
60 order to achieve a good yield. However, this problem is
eliminated when anhydrous gaseous HCI is used. Moreover,
the product quality of crude Compound III prepared by the
halogenated solvent route is much better than that of crude
Compound III prepared by the toluene or toluene/ethyl
65 acetate processes. Consequently, the yield of the isolated
Compound III is nearly 15% higher with the halogenated
solvent process. In addition, the intermediates do not have to
II 25
50In a presently preferred embodiment the Compound of
Formula II has the following formula:
In another preferred embodiment, the Compound of For-
mula III has the following general formula:
and, (b) treating the reaction mixture with an acid having a
pKa ofless than about 4 (e.g., hydrochloric acid (HCI)) until
the reaction is complete, thereby forming the Compound of
Formula III. In a presently preferred embodiment, this
process further comprises recovering the Compound of
Formula III from the reaction mixture by cooling to 5° C.
and filtering.
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting
group; and R3 is a member selected from the group con-
sisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H, alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
conjugate base of said acid.
10
in which R1 is an amino acid side chain or a functionalized
amino acid side chain; R3 is a functional group including,
but not limited to hydrogen, alkyl, cycloalkyl, aryl and
-NHP, wherein P is selected from the group consisting of
H, alkyl, cycloalkyl, aryl and a protecting group; and X- is 15
the conjugate base of an acid having a pKa of less than about
4. The process for converting a Compound of Formula II to
a Compound of Formula III comprises: (a) combining a
Compound of Formula II with an aromatic solvent/alkyl 20
acetate (e.g., toluene/ethyl acetate) to form a reaction
mixture, and heating the reaction mixture, the Compound of
Formula II having the following general formula:
US 6,548,706 B2
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In the above process, a halogenated solvent is employed.
25 Suitable halogenated solvents include, but are not limited to,
methylene chloride, chloroform, trifiuorotoluene (oxsol),
parachlorotrifiuorotoluene and trichloroethylene. In a pre-
ferred embodiment, the halogenated solvent is methylene
chloride. Suitable tertiary amines include, but are not limited
30 to, triethylamine, diisopropylethylamine, pyridine and
N-methylmorpholine. In a preferred embodiment, the ter-
tiary amine is triethylamine.
In another embodiment, the present invention provides a
process for preparing a compound having the following
35 general formula:
the process compnsmg: (a) combining a compound of
Formula II with a halogenated solvent (e.g., methylene
chloride) to form a reaction mixture and heating the reaction
mixture to a temperature ranging from about 10° C. to about
50 50° C. and, more preferably, to a temperature ranging from
about 30° C. to about 35° c., the compound of Formula II
having the following general formula:
15
II 10
t-BacHN
and, (c) adding the first reaction mixture to the second
reaction mixture to form a third reaction mixture, and
heating the third reaction mixture to a temperature ranging
from about 10° C. to about 50° C. and, more preferably, to
a temperature ranging from about 30° C. to about 35° C.
until the reaction is complete, thereby forming the com- 40
pound of Formula II. In a presently preferred embodiment,
the first reaction mixture is heated or warmed prior to adding
it to the second reaction mixture.
In the above process, R1 is an amino acid side chain or a
45functionalized amino acid side chain; R2 is a protecting
group; and R3 is a functional group including, but not
limited to, hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H, alkyl,
cycloalkyl, aryl and a protecting group.
In a presently preferred embodiment, the Compound of
Formula I has the following formula:
the process comprising: (a) combining nosyl chloride with a
halogenated solvent (e.g., methylene chloride) to form a first 20
reaction mixture; (b) combining a tertiary amine (e.g.,
triethylamine) with a compound of Formula I in a haloge-
nated solvent (e.g., methylene chloride) to form a second
reaction mixture, the compound of Formula I having the
following general formula:
11
be isolated when a halogenated solvent (e.g., methylene
chloride) is used. It is noted that, e.g., the sulfonamide
impurity is soluble in methylene chloride; otherwise, it is
very difficult to remove.
As such, in one embodiment, the present invention pro- 5
vides a process for preparing a compound having the fol-
lowing general formula:
t-BacH
In another preferred embodiment, the Compound of For-
mula II has the following formula:
II
55
60
and, (b) treating the reaction mixture with an acid having a
pKa of less than about 4 (e.g., hydrochloric acid) until the
65 reaction is complete, thereby forming the compound of
Formula III. Exemplar halogenated solvents includes, but
are not limited to, the following: methylene chloride,
US 6,548,706 B2
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the process comprising: (a) combining a halomethyl alcohol
(HMA) and an amine (e.g., isobutylamine (IBA)) in a
halogenated solvent (e.g., methylene chloride) with an acid
scavenger to form a reaction mixture, and heating the
30 reaction mixture to a temperature ranging from about 10° C.
to about 50° C. and, more preferably, to a temperature
ranging from about 30° C. to about 35° c., wherein the
HMA has the following general formula:
III
20
0.5 hours and, more preferably, for a period of time ranging
from about 1 to about 5 hours. In one preferred embodiment,
the hydrochloric acid is aqueous hydrochloric acid. In this
embodiment, the hydrochloric acid can be, for example,
about 37% aqueous hydrochloric acid. In another preferred
embodiment, the hydrochloric acid is gaseous hydrochloric
acid. In this embodiment, the gaseous hydrochloric acid can
be bubbled through the reaction mixture. In another pre-
ferred embodiment, the acid is methanesulfonic acid
10 (CH3S03H). In a presently preferred embodiment, the Com-
pound of Formula III is recovered from the reaction mixture.
In another embodiment, the present invention provides a
process for preparing a Compound of Formula III from a
HMA, the Compound of Formula III having the following
15 general formula:
t-BocHN
chloroform, trifiuorotoluene (oxsol), parachlorotrifiuoro-
toluene and tricloroethylene. In a presently preferred
embodiment, the halogenated solvent is methylene chloride.
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting 5
group; and R3 is a member selected from the group con-
sisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
conjugate base of the acid employed in the reaction.
In a presently preferred embodiment, the Compound of
Formula II has the following formula:
Cl
OH
t-BocHN
55
60
(b) adding to the first reaction mixture nosyl chloride while
stirring the reaction mixture, and recovering the organic
layer of the reaction mixture to form a solution; and (c)
45 reacting the solution with an acid having a pK
a
of less than
about 4 until the reaction is complete, thereby forming the
compound of Formula III.
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting
50 group; R3 is a functional group including, but not limited to,
hydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein P is
selected from the group consisting of H, alkyl, cycloalkyl,
aryl and a protecting group; and L is a leaving group.
In a presently preferred embodiment, the HMA is a
2S,3S-HMA. In a presently preferred embodiment, the
2S,3S-HMA has the following formula:
40
35
In step (b) of the above process, the reaction mixture is
treated or contacted with an acid having a pKa of less than
about 4. Exemplar acids include, but are not limited to, HCI,
HEr, CF3 C02 H, CF3S03 H, CH3S03 H, H2S04 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The 65
reaction mixture is treated with the acid until the reaction is
complete and, typically, for a time period of at lease about
In another preferred embodiment, the Compound of For-
mula III has the following general formula:
US 6,548,706 B2
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t-BocHN Cl.
period ranging from about 1 to about 5 hours. In one
preferred embodiment, the acid is hydrochloric acid. In
another preferred embodiment, the acid is methanesulfonic
acid (CH3S03H).
5
In yet another embodiment, the present invention pro-
vides a process for preparing a Compound of Formula III
from a compound of Formula I, the Compound of Formula
III having the following general formula:
10
III
15
20
the process comprising: (a) adding a Compound of Formula
I in a halogenated solvent (e.g., methylene chloride) with a
tertiary amine and nosyl chloride to form a reaction mixture,
and heating the reaction mixture at a temperature ranging
25 from about 10° C. to about 50° C. and, more preferably, to
a temperature ranging from about 30° C. to about 35° c.; the
compound of Formula I having the following general for-
mula:
35
30
In another presently preferred embodiment, the Compound
of Formula III has the following formula:
and (b) reacting the reaction mixture with an acid having a
pKa of less than about 4 until the reaction is complete,
40 thereby forming the Compound of Formula III.
In the above process, an amine is combined with a
halogenated solvent. Suitable amines include, but are not
limited to, primary amines, secondary amines, substituted
amines, hydrazines and substituted hydrazines. Exemplar
amines include, but are not limited to, methylamine,
ethylamine, isopropylamine, n-butylamine, isobutylamine, 45
cyclohexylamine, benzylamine, paranitrobenzylamine,
dimethylamine, isobutylmethylamine, decahyroquinoline,
decahydroisoquinoline, pyrimidine, isobutylhydrazine and
t-Boc-hydrazine. In a preferred embodiment, the amine is a
primary amine. In a presently preferred embodiment, the 50
amine is isobutylamine (lEA), preferably neat lEA. In the
above process, a halogenated solvent is employed. Exemplar
halogenated solvents includes, but are not limited to, the
following: methylene chloride, chloroform, trifiuorotoluene
(oxsol), parachlorotrifiuorotoluene and trichloroethylene. In 55
a presently preferred embodiment, the halogenated solvent
is methylene chloride.
In step (c) of the above process, the solution from step (b) 60
is treated or contacted with an acid having a pKa of less than
about 4. Exemplar acids include, but are not limited to, HCI,
HBr, CF3 C02 H, CF3S03 H, CH3S03 H, H2S04 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The
solution is treated with the acid until the reaction is com- 65
plete. Typically, the solution is treated for a time period of
at lease about 0.5 hours and, more preferably, for a time
In the above process, R1 is an amino acid side chain or a
functionalized amino acid side chain; R2 is a protecting
group; and R3 is a member selected from the group con-
sisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
conjugate base of the acid used in step (b).
In a presently preferred embodiment, the Compound of
Formula I has the following formula:
In another preferred embodiment, the Compound of For-
mula III has the following formula:
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EXAMPLES
A. Preparation of Compound I
I. Process A: Toluene/Ethyl Acetate Process:
A mixture of 2S,3S-CMA (251.8 g, 0.84 mol), isobuty-
lamine 737.8 g (10.1 mol) and sodium hydrogen carbonate
(77.6 g, 92 mol) in water (323.9 g) is heated at a gentle reflux
(_60° C.) for 5 h. Water (1000 g) is added and excess
isobutyl amine is removed by distillation under nitrogen at
an internal reaction temperature of 70° C. (The recovery is
approximately 85% and the recovered IBAcan be recycled).
Additional water (500 g) is added and the product is isolated
60 by filtration. The precipitated solid is washed with water and
dissolved in toluene (1500 g). The solution is reduced in
volume by 1/3 by distillation at 70° C. under reduced pressure
(300 mm-Hg) to remove water and residual isobutylamine.
The solution of Compound I in toluene is used directly in
synthesis of Compound II. However, in order to obtain
yield/purity data, Compound I is isolated by evaporation of
the solvent and the resulting solid is dried in oven to constant
i-propyl, 2-propenyl (or allyl), n-butyl, t-butyl, i-butyl (or
2-methylpropyl), etc. As used herein, the term alkyl encom-
passes "substituted alkyls." Substituted alkyl refers to alkyl
as just described including one or more functional groups
5 such as lower alkyl, aryl, aralkyl, acyl, halogen (i.e.,
alkylhalos, e.g., CF3), hydroxy (e.g., hydroxymethyl),
amino, alkylamino, acylamino, acyloxy, alkoxy (e.g.,
methoxymethyl), mercapto and the like. These groups may
be attached to any carbon atom of the lower alkyl moiety.
The term "cycloalkyl," by itself or in combination with
other terms, represents cyclic versions of "alkyl." Examples
of cycloalkyl include cyclopentyl, cyclohexyl,
1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like.
The cycloalkyl group may be substituted or unsubstituted.
The term "alkoxy" is used herein to refer to the -OR
group, where R is a lower alkyl, substituted lower alkyl, aryl,
substituted aryl, aralkyl or substituted aralkyl. Suitable
alkoxy radicals include, for example, methoxy, ethoxy,
phenoxy, t-butoxy (e.g., methoxyethoxy, methoxymethoxy,
20 etc.), etc.
The term "aryl," as used herein, refers to an aromatic
substituent which may be a single ring or multiple rings
which are fused together, linked covalently, or linked to a
common group such as an ethylene or methylene moiety.
25 The aromatic ring(s) may include phenyl, naphthyl,
biphenyl, diphenylmethyl, 2,2-diphenyl-1-ethyl, and may
contain a heteroatom, such as thienyl, pyridyl and quinox-
alyl. The aryl group may also be substituted with halogen
atoms, or other groups such as nitro, carboxyl, alkoxy,
30 phenoxy, and the like. Additionally, the aryl group may be
attached to other moieties at any position on the aryl radical
which would otherwise be occupied by a hydrogen atom
(such as 2-pyridyl, 3-pyridyl and 4-pyridyl).
In view of the foregoing, it will be readily apparent to
35 those of skill in the art that the foregoing processes can be
used to prepare not only the 2S,3S-derivative, but also the
2R,3S-, 2S,2R- and the 2R,3R-derivatives. Again, the pro-
cess of the present invention results in higher yields of these
derivatives, while not sacrificing their purity.
The invention will be described in greater detail by way
of specific examples. The following examples are offered for
illustrative purposes, and are not intended to limit the
invention in any manner. Those of skill in the art will readily
recognize a variety of non-critical parameters which can be
45 changed or modified to yield essentially the same results.
10
In the above process, a tertiary amine is combined with a
halogenated solvent. Suitable tertiary amines include, but 15
are not limited to, triethylamine, diisopropylethylamine,
pyridine and N-methylmorpholine. In a presently preferred
embodiment, triethylamine is used. Exemplar halogenated
solvents includes, but are not limited to, the following:
methylene chloride, chloroform, trifluorotoluene (oxsol),
parachlorotrifluorotoluene and trichloroethylene. In a pres-
ently preferred embodiment, the halogenated solvent is
methylene chloride.
In step (b) of the above process, the reaction mixture is
reacted with an acid having a pKa of less than about 4.
Exemplar acids include, but are not limited to, HCI, HBr,
CF3 C02 H, CF3S03H, CH3S03 H, H2S04 , citric acid, tar-
taric acid, oxalic acid and p-toluene sulfonic acid. The
solution is treated with the acid until the reaction is com-
plete. Typically, the solution is treated for a time period of
at least about 0.5 hours and, more preferably, for a time
period ranging from about 1 to about 5 hours. In one
preferred embodiment, the acid is hydrochloric acid. In
another preferred embodiment, the acid is methanesulfonic
acid (CH3S03H).
In a presently preferred embodiment, the process further
comprises washing 20 the reaction mixture; heating the
reaction mixture to a temperature ranging from about 40° C.
to about 45° c.; and then azeotropically drying the reaction
mixture prior to step (b). In another preferred embodiment,
the Compound of Formula III is recovered from the reaction 40
mixture. In one such embodiment, the recovery step com-
prises: (i) cooling the reaction mixture to a temperature of
about _5° c.; (ii) filtering the reaction mixture to remove the
N-isobutyl-p-nitrobenzenesulfonamide impurities and pro-
vide the compound of Formula III; and (iii) washing the
compound of Formula III and then drying it in vacuo.
Using the above processes, 2S,3S-N-isobutyl-N-(2-
hydroxy-3 - amino -4-phenylbu tyl) -p-
nitrobenzenesulfonylamide hydrochloride can be prepared
directly from the chloromethylalcohol (CMA) without hav- 50
ing to isolate the Boc-epoxide. The process of the present
invention is the first demonstration of a process wherein a
protease inhibitor intermediate is prepared directly from the
halomethylalcohol. Again, this is extremely helpful because
elimination of the epoxide eliminates the need to isolate a 55
toxic intermediate (i.e., a mutagen) and, thus, circumvents
safety issues involved with dust explosivity of the Boc-
epoxide. Importantly, the process of the present invention
results in higher yields of Compound III, while not sacri-
ficing its purity.
Those of skill in the art will readily understand that the
term "alkyl," as used herein, refers to a branched or
unbranched, saturated or unsaturated, monovalent hydrocar-
bon radical having from 1-12 carbons and, preferably, from
1-6 carbons. When the alkyl group has from 1-6 carbon 65
atoms, it is referred to as a "lower alkyl." Suitable alkyl
radicals include, for example, methyl, ethyl, n-propyl,
US 6,548,706 B2
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said process comprising: combining a halomethyl alcohol
(HMA) with an amine and an acid scavenger to form a
reaction mixture, and heating said reaction mixture until the
reaction is complete, thereby forming the compound of
Formula I; wherein said HMA has the following general
formula:
20
40
wherein:
R1 is an amino acid side chain or a functionalized amino
acid side chain;
R2 is a protecting group;
R3 and R4 are independently selected from the group
consisting of hydrogen, alkyl, cycloalkyl, aryl and
-NHP, wherein P is selected from the group consisting
of H, alkyl, cycloalkyl, aryl and a protecting group, or
R3 and R4 together form a cyclic structure selected
from the group consisting of quinoline and isoquino-
line; and
X is a leaving group.
2. The process in accordance with claim 1, wherein said
60 HMA is a 2S,3S-HMA.
3. The process in accordance with claim 1, wherein X is
a halogen.
4. The process in accordance with claim 3, wherein X is
chloro or bromo.
5. The process in accordance with claim 1, wherein R1 is
a member selected from the group consisting of an alkyl
group, a benzyl group, a phenyl thiomethyl group, a pro-
solution was cooled to ambient. Hydrogen chloride gas was
passed through the solution for 3 h until HPLC analysis
indicated that the reaction was complete. The mixture was
cooled to 0-5° C. and filtered to give a white solid. The solid
5 was washed with hexanes (65 mL) and dried in vacuo to give
59.5 g (89%) of compound III that was 99.7% pure by HPLC
analysis.
It is understood that the examples and embodiments
described herein are for illustrative purposes only and that
10 various modifications or changes in light thereof will be
suggested to persons skilled in the art and are to be included
within the spirit and purview of this application and scope of
the appended claims. All publications, patents, and patent
applications cited herein are hereby incorporated by refer-
15 ence for all purposes.
What is claimed is:
1. A process for the preparation of a compound having the
following general formula:
A. One Pot Process
II. Process B: Methylene Chloride Process
A solution of 2S,3S-CMA (44 g, 0.146 mol), isobuty-
lamine (11 g, 0.150 mol) in 270 mL of methylene chloride
was stirred with sodium hydrogen carbonate (33 g, 0.4 mol) 45
in water (100 g) for 5 h. is heated at a gentle reflux (-30° C.)
for 6 h. Then nosyl chloride (35.4 g, 0.157 moles) and
triethylamine (17.7 g, 0.175 moles) was added and the
mixture stirred for 6 h at 30-35° C. The organic layer was
removed and the residue washed with water (100 mL). 50
Gaseous HCl was bubbled through the solution for 2-3
hours until the reaction was complete as indicated by HPLC
analysis. The residual acid is removed with a stream of
nitrogen gas and the reaction mixture was cooled to _5° C.
for 1 h. The mixture was filtered to give 60 g (89%) of 55
Compound III with 99.7% purity by HPLC.
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weight. The yields normally range in the neighborhood of
98.5 to 99% with purities (HPLC) ranging in the neighbor-
hood of 98.7 to 98.8%. The isolated product was character-
ized by 1H/13C NMR and by HPLC/TLC analysis.
B. Preparation of Compound II
Solution of Compound I in toluene was warmed to 70° C.
and treated with triethylamine (220 g, 2.18 mol). Then, a
solution of p-nitrobenzenesulfonyl chloride (195 g, 0.88
mol) in ethyl acetate (1 1) was added over 3 h. The organic
mixture was then washed sequentially at 65-70° C. with
water (400 mL), 5% aqueous sodium hydrogen carbonate
(400 mL) and water (400 mL). The product is obtained as a
solution in toluene/ethyl acetate and is used directly in
synthesis of Compound III. The yields, as determined by
evaporating the solvent and isolating crude Compound II,
were in the neighborhood of 97 to 98%.
C. Preparation of Compound III
The solution of Compound II in toluene/ethyl acetate at
65° C.-70° C. was treated with 37% aqueous hydrochloric
acid (160 g, 1.64 mol) over a period of 2 h. The mixture was
then distilled at 70° C. under reduced pressure (500-600
mm-Hg) until the residual ethyl acetate content was less than 25
5 mol % in toluene (as determined by lH NMR analysis),
and the water content was less than 1% (as determined by
Karl Fischer analysis). When distillation was complete, the
toluene volume was adjusted to 15% solids and ethanol (360
mL, denatured with 5 wt % Methanol) was added. The 30
mixture was cooled to ambient temperature over 2 h, held at
ambient for 1 h, then cooled to _5° C. to _10° C. for 1 h. The
precipitated solid was isolated by filtration, washed with
toluene and n-hexanes, and dried in vacuo at 80° C. to give
247 g (73%) of Compound III. The purity of Compound III 35
as determined by HPLC was 99.2 wt % (99.8 area%).
Compound III was also characterized by 1H/13C NMR
analysis.
B. Process Starting with Compound I
A solution of triethylamine (17.7 g, 0.175 mol) and
Compound I (49.0 g 1.46 mol) in methylene chloride (270
mL) was heated to 30-35° C. and nosyl chloride (35.4 g,
0.157 mol) in methylene chloride was added over 3 h. The
solution is heated to 35° C. and washed sequentially with
water (65 mL), 5% sodium bicarbonate solution (60 mL) and
water (80 mL). The solution was heated reflux and water 65
removed azeotropically. When Karl Fischer analysis of the
solution indicated that less than 0.1% of water remained, the
US 6,548,706 B2
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tected hydroxymethyl group, an S-alkyl group and a
nitrobenzyl group.
6. The process in accordance with claim 1, wherein R2 is
a protecting group selected from the group consisting of
t-Boc, i-Boc, Moc, Cbz and Fmoc.
7. The process in accordance with claim 2, wherein said
2S,3S-HMA has the following general formula:
t-BocHN
OH
Cl.
22
13. The process in accordance with claim 1, wherein said
acid scavenger is potassium bicarbonate.
14. The process in accordance with claim 1, wherein
about 0.5 to about 2 equivalents of said acid scavenger is
5 present in said reaction mixture.
15. The process in accordance with claim 1, wherein
about 1 equivalent of said acid scavenger is present in said
reaction mixture.
10 16. The process in accordance with claim 1, wherein said
reaction mixture is heated to a temperature ranging from
about 50° C. to about 100° C.
17. The process in accordance with claim 1, wherein said
reaction mixture is heated to a temperature ranging from
15 about 60° C. to about 75° C.
18. The process in accordance with claim 7, wherein said
compound of Formula I has the following general formula:
8. The process in accordance with claim 1, wherein said
amine is a member selected from the group consisting of
primary amines, secondary amines, substituted amines, 20
hydrazines and substituted hydrazines.
9. The process in accordance with claim 1, wherein said
amine is a member selected from the group consisting of
methylamine, ethylamine, isopropylamine, n-butylamine,
isobutylamine, cyclohexylamine, benzylamine, para- 25
nitrobenzylamine, dimethylamine, isobutylmethylamine,
decahyroquinoline, decahydroisoquinoline, pyrimidine,
isobutylhydrazine and t-Boc-hydrazine.
10. The process in accordance with claim 1, wherein said
amine is isobutylamine (IBA). 30
11. The process in accordance with claim 1, wherein said
acid scavenger has the general formula M+B-, wherein M+
is selected from the group consisting of K+, Na+, Li+, Ca+2 ,
Mg+2 and Al+2 ; and B- is selected from the group consisting
of -OH, HC03 - and C03 - 2 . 3512. The process in accordance with claim 1, wherein said
acid scavenger is sodium bicarbonate.
OH
19. The process in accordance with claim 1, wherein said
compound of Formula I is recovered from said reaction
mixture by filtration of said compound of Formula I and
drying said compound of Formula I.
* * * * *
